Sophia A Mahoney

12PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyMolecular targetsCardiology (incl. cardiovascular diseases)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 17, 2026
Fisetin Supplementation Attenuates Premature Vascular Aging Induced by Doxorubicin via Suppression of Cellular Senescence and Mitochondrial Oxidative Stress.

|Apr 23, 2026
Senolytic Treatment With Fisetin Reverses Age-Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12.

|Jan 12, 2026
Late-Onset Menopause Attenuates Aortic Stiffness in the Postmenopausal Period.

Sanna Darvish, Kevin O Murray, Sophia A Mahoney

|Oct 27, 2025
Cellular senescence mediates doxorubicin chemotherapy-induced vascular endothelial dysfunction: translational evidence of prevention with senolytic treatment.

Ravinandan Venkatasubramanian, Sophia A Mahoney, David A Hutton

|Sep 12, 2025
Mechanisms of cellular senescence-induced vascular aging: evidence of senotherapeutic strategies.

Sophia A Mahoney, Samuel I Bloom, Douglas R Seals

|Sep 02, 2025
Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12.

Sophia A Mahoney, Krystyna Mazan-Mamczarz, Dimitrios Tsitsipatis

Pageof 2

Frequent Collaborators

8 joint publications

Zachary S Clayton

7 joint publications

Douglas R Seals

6 joint publications

Matthew J Rossman

4 joint publications

Kevin O Murray